Cellebrite

An Israeli company unveils a mobile tactical kit that allows frontline soldiers to extract critical information from phones and drones in real-time, without the need for a rear laboratory or network connection.

The digital intelligence company reported a 16% growth in revenue for the second quarter, but failed to beat market expectations and lowered its forecasts for the future. At the same time, it announced a change of CEOs. Meanwhile, on Wall Street, the 'buy' recommendation for the stock is being maintained.

Israel's Cellebrite is appointing a new CEO and lowering its 2026 guidance. Following the announcement, the company's stock plunged more than 20% in premarket trading on the Nasdaq.